Itamar Medical

Home Sleep Testing and Endothelial Function Assessment

Health Tech & Life Sciences
Acquired by ZOLL Medical on Sep 2021

Company Overview

Snapshot

Founded in January 1997, Itamar Medical operates with 201–500 employees. The company raised a total of $190.45 million across 10 funding rounds from 11 investors. A significant milestone was its acquisition by ZOLL Medical in September 2021.

Business overview

Itamar Medical is a medical device company specializing in integrating sleep apnea management into cardiac patient care pathways. The company develops, manufactures, and sells the FDA-cleared WatchPAT diagnostic product line, which uses PAT technology for simple, comprehensive, and reliable sleep apnea testing. Additionally, Itamar Medical markets the EndoPAT system, an endothelial function assessment tool for risk classification. The company serves clinicians, researchers, and pharmaceutical companies, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices.

Strategic signal

Itamar Medical's acquisition by ZOLL Medical in September 2021 for $538 million signals a strong validation of its technology and market position within the sleep apnea and cardiovascular health sectors. This strategic integration into a larger medical device company suggests an expanded reach for its diagnostic products and a potential acceleration of its mission to link sleep apnea management with cardiac care, indicating robust future growth prospects under new ownership.

Company Intelligence Q&A

What was a significant exit event for Itamar Medical?
Itamar Medical was acquired by ZOLL Medical in September 2021 for $538 million, as reported by Calcalistech. This acquisition marked a significant milestone for the company, integrating its sleep apnea management technology into a larger medical device entity.
What was Itamar Medical's last public offering event?
In February 2021, Itamar Medical had a public offering on TASE, raising $70 million.
Which company did Itamar Medical acquire?
In January 2021, Itamar Medical acquired the technology and assets of Spry Health.
What was a key strategic partnership for Itamar Medical in 2019?
In March 2019, Lofta partnered with Itamar Medical for home sleep testing solutions.
What product approval did Itamar Medical receive in Japan?
In October 2020, Itamar Medical's WatchPAT™300 Home Sleep Apnea Testing Device received approval in Japan.

External links